Advertisement
Advertisement
SUPN
Supernus Pharmaceuticals, Inc.
47.64
USDSponsored
+0.88
+1.88%
Aug 07, 15:59 UTC -4
Closed
After-Market
47.62
-0.02
-0.05%
SUPN Earnings Reports
Positive Surprise Ratio
SUPN beat 31 of 42 last estimates.
74%
Next Report
Date of Next Report
Oct 29, 2026
Estimate for Q3 26 (Revenue/ EPS)
$223.54M
/$0.60
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
+16.36%
/-40.59%
Supernus Pharmaceuticals, Inc. earnings per share and revenue
On Aug 04, 2026, SUPN reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of 0.42 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 209.06 million, with a --% difference. The market reacted with a +8.46% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of 0.60 USD, with revenue projected to reach 223.54 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Bausch Health Companies Inc
Report Date
Jul 29, 2026 For Q2 26
Estimate
$1.04
Actual
$1.26
Surprise
+20.34%
Teva Pharmaceutical Industries Limited - ADR
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.25
Actual
$0.02
Surprise
-92.05%
Amphastar Pharmaceuticals, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.63
Actual
$0.91
Surprise
+43.87%
FAQ
What were Supernus Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Supernus Pharmaceuticals, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Supernus Pharmaceuticals, Inc.'s Q2 2026 earnings?
The stock price moved up 8.46%, changed from $43.25 before the earnings release to $46.91 the day after.
When is Supernus Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for Oct 29, 2026.
What are the forecasts for Supernus Pharmaceuticals, Inc.'s next earnings report?
Based on 6
analysts, Supernus Pharmaceuticals, Inc. is expected to report EPS of $0.60 and revenue of $223.54M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement